相似文献
1
Dangerous pathogens in the laboratory: from smallpox to today's SARS setbacks and tomorrow's polio-free world.
Lancet. 2004 May 15;363(9421):1566-8. doi: 10.1016/S0140-6736(04)16234-X.
2
Infectious diseases. Mounting lab accidents raise SARS fears.
Science. 2004 Apr 30;304(5671):659-61. doi: 10.1126/science.304.5671.659.
3
Severe acute respiratory syndrome: lab accidents prompt calls for new containment program.
Science. 2004 May 28;304(5675):1223-5. doi: 10.1126/science.304.5675.1223a.
4
Infectious diseases. SARS experts want labs to improve safety practices.
Science. 2003 Oct 3;302(5642):31. doi: 10.1126/science.302.5642.31a.
5
SARS under control, but lab-safety questions remain.
Lancet. 2004 May 29;363(9423):1780. doi: 10.1016/S0140-6736(04)16344-7.
6
Infectious diseases. Second lab accident fuels fears about SARS.
Science. 2004 Jan 2;303(5654):26. doi: 10.1126/science.303.5654.26.
7
Editorial: Confinement of the poxvirus.
Lancet. 1974 Sep 7;2(7880):561-2.
8
Infectious diseases. Singapore lab faulted in SARS case.
Science. 2003 Sep 26;301(5641):1824. doi: 10.1126/science.301.5641.1824b.
9
Breaches of safety regulations are probable cause of recent SARS outbreak, WHO says.
BMJ. 2004 May 22;328(7450):1222. doi: 10.1136/bmj.328.7450.1222-b.
10
Interview with David L. Heymann, MD, representative for polio eradication and former Executive Director, Communicable Diseases, World Health Organization. Interview by Madeline Drexler.
Biosecur Bioterror. 2003;1(4):233-7. doi: 10.1089/153871303771861423.
引用本文的文献
1
Comparing and contrasting two United Nations Environment Programme reports on COVID-19.
Sci One Health. 2022 Nov 5;1:100003. doi: 10.1016/j.soh.2022.100003. eCollection 2022 Nov.
2
Artificial intelligence-based prediction of pathogen emergence and evolution in the world of synthetic biology.
Microb Biotechnol. 2024 Oct;17(10):e70014. doi: 10.1111/1751-7915.70014.
3
Biorisk Management Features of a Temporary COVID-19 Hospital.
Appl Biosaf. 2023 Mar 1;28(1):32-42. doi: 10.1089/apb.2022.0018. Epub 2023 Mar 6.
4
There is no "origin" to SARS-CoV-2.
Environ Res. 2022 May 1;207:112173. doi: 10.1016/j.envres.2021.112173. Epub 2021 Oct 6.
5
Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution.
Front Microbiol. 2021 Sep 20;12:675528. doi: 10.3389/fmicb.2021.675528. eCollection 2021.
6
An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
Lancet. 2021 Oct 16;398(10309):1402-1404. doi: 10.1016/S0140-6736(21)02019-5. Epub 2021 Sep 17.
7
Risk awareness during operation of analytical flow cytometers and implications throughout the COVID-19 pandemic.
Cytometry A. 2021 Jan;99(1):81-89. doi: 10.1002/cyto.a.24282. Epub 2020 Dec 23.
8
Understanding the origin of COVID-19 requires to change the paradigm on zoonotic emergence from the spillover to the circulation model.
Infect Genet Evol. 2021 Nov;95:104812. doi: 10.1016/j.meegid.2021.104812. Epub 2021 Mar 18.
9
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol.
Front Cardiovasc Med. 2021 Jan 15;7:618651. doi: 10.3389/fcvm.2020.618651. eCollection 2020.
10
The biosecurity benefits of genetic engineering attribution.
Nat Commun. 2020 Dec 8;11(1):6294. doi: 10.1038/s41467-020-19149-2.
本文引用的文献
1
Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?
Bull World Health Organ. 2004 Jan;82(1):59-62. Epub 2004 Feb 26.
2
Polio control after certification: major issues outstanding.
Bull World Health Organ. 2004 Jan;82(1):47-52. Epub 2004 Feb 26.
3
The role of routine polio immunization in the post-certification era.
Bull World Health Organ. 2004 Jan;82(1):31-9. Epub 2004 Feb 26.
4
Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995).
J Infect Dis. 1997 Sep;176(3):617-24. doi: 10.1086/514081.
Zotero 插件